|
|
 |
|
|
 |
Featured Studies & Reports
Alzheimer’s Burden Will Balloon if New Treatments Are Not Found
15 May, 2010 - A new report from the Alzheimer’s Association examines the future impact of Alzheimer’s disease and the potential impact of new treatments. The study finds that on our current trajectory Alzheimer’s disease in adults over 65 will cost $1 trillion per year by 2050 and a total of $20 trillion in the next 40 years.
Complexity and Execution Burden of Clinical Trials Are Rising
5 May, 2010 - A recent report by Tufts Center for the Study of Drug Development (CSDD) finds that clinical trials are continuing to become more complex and time-consuming. Between 2000-03 and 2004-7, the median number of procedures per clinical trial increased by 49% while the total work burden per protocol grew by 54%.
Recognizing Value in Oncology Innovation
15 March, 2010 - Boston Healthcare Associates released a report which describes how our understanding of the clinical role and value of new cancer treatments evolves over time after they are introduced, and how new treatments with seemingly modest benefits at the time of FDA approval often demonstrate significant clinical advantages for patients over time.
Major Advances in Cancer Medicines in 2009
10 December, 2009 - A new report from the American Society of Clinical Oncology (ASCO) highlighted 51 of the most significant findings of 2009, including 15 major advances that the authors believe “have the potential to lead to a reduction in mortality from cancer”.
|
|
